Health : Diseases, Disorders, and Disciplines

Crohn's & Colitis Foundation

Working to cure Crohn's disease and ulcerative colitis

83.16

733 Third Avenue Suite 510
New York, NY 10017
tel: (800) 932-2423   Web Site
EIN: 13-6193105

Board Leadership
Brent Polk
Chair

CEO
Michael Osso
President, CEO

  Score
(out of 100)
Rating
Overall Score & Rating 83.16
  Financial 76.38
  Accountability & Transparency 97.00
This rating was published 10/01/2021 and includes data from FY2019, the most recent 990 received at that time.

The Crohn's & Colitis Foundation is a leading supporter and founder of medical research in Crohn's disease and ulcerative colitis-collectively known as inflammatory bowel diseases (IBD). We invest our dollars wisely, funding the best IBD research globally and implementing a peer-review process insuring that only the most promising and relevant grant applications are funded. With more than 1000 grants awarded, the foundation played a role in every major scientific breakthrough in IBD, from generating data leading to new therapies to the discovery of the first gene for Crohn's disease. The foundation supports Basic and Clinical research. Basic research studies the complex interactions between genes, bacteria, and the immune response in IBD. Foundation-sponsored research led to breakthrough discoveries in the role genetics and the human microbiome play in IBD onset and progression. We are establishing the largest research and information exchange to develop better treatments and cures.

The Crohn's & Colitis Foundation is a leading supporter and founder of medical research in Crohn's disease and ulcerative colitis-collectively known as inflammatory bowel diseases (IBD). We invest our dollars wisely, funding the best IBD research globally and implementing a peer-review process insuring that only the most promising and relevant grant applications are funded. With more than 1000 grants awarded, the foundation played a role in every major scientific breakthrough in IBD, from generating data leading to new therapies to the discovery of the first gene for Crohn's disease. The foundation supports Basic and Clinical research. Basic research studies the complex interactions between genes, bacteria, and the immune response in IBD. Foundation-sponsored research led to breakthrough discoveries in the role genetics and the human microbiome play in IBD onset and progression. We are establishing the largest research and information exchange to develop better treatments and cures.

Financial

76.38

Accountability & Transparency

97.00

This rating was published 10/01/2021 and includes data from FY2019, the most recent 990 received at that time.
Overall Rating Chart
  Program Expenses
(Percent of the charity's total expenses spent on the programs
and services it delivers)
80.7%
  Administrative Expenses 12.7%
  Fundraising Expenses 6.5%
  Fundraising Efficiency $0.07
  Working Capital Ratio (years) 0.11
  Program Expenses Growth 1.6%
  Liabilities to Assets 80.5%
All data for Financial Performance Metrics calculations was provided by Crohn's & Colitis Foundation on recent 990s filed with the IRS.
All data for Financial Performance Metrics calculations was provided by Crohn's & Colitis Foundation on recent 990s filed with the IRS.
REVENUE  
Contributions  
   Contributions, Gifts & Grants $35,871,906
   Federated Campaigns $1,184,804
   Membership Dues $0
   Fundraising Events $28,767,167
   Related Organizations $0
   Government Grants $581,443
Total Contributions $66,405,320
   Program Service Revenue $5,275,500
Total Primary Revenue $71,680,820
   Other Revenue $2,244,430
TOTAL REVENUE $73,925,250
   
EXPENSES  
   Program Expenses $60,727,381
   Administrative Expenses $10,145,624
   Fundraising Expenses $4,850,525
TOTAL FUNCTIONAL EXPENSES $75,723,530
   
Payments to Affiliates $0
Excess (or Deficit) for the year $-1,798,280
   
Net Assets $8,818,349

Charts

Compensation % of Expenses Paid to Title
$472,836 0.62% Michael Osso President, CEO

Mission

The Crohn's & Colitis Foundation is a leading supporter and founder of medical research in Crohn's disease and ulcerative colitis-collectively known as inflammatory bowel diseases (IBD). We invest our dollars wisely, funding the best IBD research globally and implementing a peer-review process insuring that only the most promising and relevant grant applications are funded. With more than 1000 grants awarded, the foundation played a role in every major scientific breakthrough in IBD, from generating data leading to new therapies to the discovery of the first gene for Crohn's disease. The foundation supports Basic and Clinical research. Basic research studies the complex interactions between genes, bacteria, and the immune response in IBD. Foundation-sponsored research led to breakthrough discoveries in the role genetics and the human microbiome play in IBD onset and progression. We are establishing the largest research and information exchange to develop better treatments and cures.

Highly Rated

Charity Name & State Overall Score Overall Rating
Crohn's & Colitis Foundation (NY) 83.16
Epilepsy Foundation (MD) 89.13
Glaucoma Research Foundation (CA) 91.03
Creutzfeldt-Jakob Disease Foundation (OH) 93.66
Immune Deficiency Foundation (MD) 92.70

Compare These Charities (Highly Rated)

Charity Contact Info

Crohn's & Colitis Foundation
733 Third Avenue
Suite 510
New York, NY 10017
tel: (800) 932-2423
fax: (212) 779-4098
EIN: 13-6193105

Visit Web Site

Board Leadership

Brent Polk
Chair

CEO

Michael Osso
President, CEO